在结核病复发后重新使用肿瘤坏死因子α拮抗剂是否安全？ - Suppr

Suppr

超能文献

Is it safe to readminister tumor necrosis factor alpha antagonists following tuberculosis flare?

作者信息

Aslanidis Spyros, Pyrpasopoulou Athina, Douma Stella, Petidis Konstantinos

机构信息

Hippokration General Hospital, Thessaloniki, Greece.

出版信息

Arthritis Rheum. 2008 Jan;58(1):327-8. doi: 10.1002/art.23210.

DOI:10.1002/art.23210

PMID:18163500

Abstract

摘要

相似文献

Is it safe to readminister tumor necrosis factor alpha antagonists following tuberculosis flare?

Arthritis Rheum. 2008 Jan;58(1):327-8. doi: 10.1002/art.23210.

Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).

Dermatology. 2008;217(4):380. doi: 10.1159/000162180. Epub 2008 Oct 10.

Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.

Arthritis Rheum. 2004 Apr 15;51(2):301-2. doi: 10.1002/art.20242.

Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon?

Arch Dermatol. 2008 Jun;144(6):817-8. doi: 10.1001/archderm.144.6.817.

Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma.

Scand J Rheumatol. 2007 Nov-Dec;36(6):484-6. doi: 10.1080/03009740701281293.

Concerns regarding the readministration of tumor necrosis factor alpha antagonists following tuberculosis flare: comment on the concise communication by Aslanidis et al.

Arthritis Rheum. 2008 Sep;58(9):2923-4. doi: 10.1002/art.23790.

Biologic agents and alopecia areata.

Dermatology. 2009;218(2):184-5. doi: 10.1159/000174826. Epub 2008 Nov 18.

Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.

Acta Derm Venereol. 2009;89(4):432-3. doi: 10.2340/00015555-0633.

Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.

J Rheumatol. 2011 Mar;38(3):574; author reply 575. doi: 10.3899/jrheum.100947.

Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis.

Arthritis Rheum. 2006 Feb 15;55(1):150-3. doi: 10.1002/art.21707.

引用本文的文献

Lethal disseminated tuberculosis in patients under biological treatment - two clinical cases and a short review.

J Int Med Res. 2018 Jul;46(7):2961-2969. doi: 10.1177/0300060518771273. Epub 2018 May 23.

Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy.

Rheumatol Int. 2016 Dec;36(12):1719-1725. doi: 10.1007/s00296-016-3575-3. Epub 2016 Oct 3.

Safe re-administration of tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis or ankylosing spondylitis who developed active tuberculosis on previous anti-TNFα therapy.

J Korean Med Sci. 2014 Jan;29(1):38-42. doi: 10.3346/jkms.2014.29.1.38. Epub 2013 Dec 26.

Tuberculosis complicated by immune reconstitution inflammatory syndrome in a patient on anti-TNFα therapy for Crohn's disease.

BMJ Case Rep. 2011 Mar 8;2011:bcr0920103376. doi: 10.1136/bcr.09.2010.3376.

Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review.

Clin Rheumatol. 2012 Feb;31(2):203-10. doi: 10.1007/s10067-011-1902-3. Epub 2011 Dec 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验